|
27 ΜARCH 2021 |
|
|
PRESIDENTS OF SEMINAR: Konstantinos Dinas, Alexios Papanikolaou, Frederic Guyon |
|
|
ORGANIZING MODERATOR: Stamatios Petousis |
 |
|
08:30-10:00 |
Round Table 1. Conservative management of gynaecological cancer |
|
|
Presidents: Alexios Papanikolaou, Pavlos Papakotoulas |
|
|
1.Conservative management of endometrial cancer. When, how, to whom? Anastasios Liberis |
|
|
2.Cervical cancer: could chemoradiotheapy replace all surgical treatment? Konstantina Mponiou |
|
|
3.Ovarian cancer: could neoadjuvant chemotherapy replace surgery? Anne Floquet - Coriolan Lebreton |
|
|
4.Chemotherapy in gynaecological cancer: special considerations in the context of COVID-pandemic Eleni Timotheadou |
|
|
|
|
|
Commentary: Dimitrios Tsolakidis, George Androutsopoulos |
|
|
|
10:00-11:45 |
Round Table 2. Minimizing surgical radicality |
|
|
Presidents: Alexandros Rodolakis, Evangelos Paraskevaidis |
|
|
1. When is lymphadenectomy essential in endometrial cancer surgery? Stamatios Petousis |
|
|
2. Laparoscopic sentinel node in endometrial cancer to reduce surgical morbidity: always, sometimes or never? Angelos Daniilidis |
|
|
3. Simple hysterectomy instead of radical hysterectomy for early-stage cervical cancer. Does it indeed compromise outcome? Alexios Papanikolaou |
|
|
4. Avoiding unnecessary surgical treatment of cervical intraepithelial neoplasia. Why and how? Evangelos Paraskevaidis |
|
|
5. Minimally invasive treatment of ovarian cancer: is indeed feasible? Frederic Guyon |
|
|
|
|
|
Commentary: Ioannis Kalogiannidis, Dimitrios Chaidopoulos, Emmanouil Kontomanolis |
|
|
|
11:45-12:00 |
Break |
|
|
|
12:00-12:30 |
PLENNARY SESSION 1 |
|
|
President: Frederic Guyon |
|
|
COVID-19 era. Has it indeed alter our surgical approach? |
|
|
Professor Ranjit Manchanda |
|
|
|
12:30-13:00 |
PLENNARY SESSION 2 |
|
|
President: Konstantinos Dinas |
|
|
Robotic surgery in the treatment of gynaecological cancer during COVID-19 pandemic. What is the added value? |
|
|
Dr. Angelos Sioutas |
|
|
|
13:00-13:45 |
Round Table 3. Optimizing protocols of postoperative treatment |
|
|
Presidents: Alexandros Daponte, Eleni Katsika |
|
|
1. Lack of Intensive Care Unit availability. How should this change surgical treatment? Dimitris Vaikos |
|
|
2. Sarcopeny as modifiable risk factor for ovarian cancer patients. Time to establish as standard care? Chrysoula Margioula-Siarkou - Jean-Pierre Gekiere |
|
|
|
|
|
Commentary: George Mavromatidis, Konstantinos Katsanoulas |
|
|
|
13:45-14:00 |
Break |
|
|
|
14:00-14:30 |
PLENARY SESSION 3 |
|
|
Acquiring ESGO accreditation for 2nd Department of Obstetrics and Gynaecology. The trip to the dream. |
|
|
Κonstantinos Dinas |
|
|
|
14:30-14:45 |
PLENARY SESSION 4 |
|
|
The Importance of Adapting Activities to the Pandemic Reality: the ENYGO Experience |
|
|
Zoia Razumova |
|
|
|
14:45-15:00 |
Round Table 4. Multidisciplinary Tumour Board: presentation and live discussion of two relative cases |
|
|
Presentation: Chrysoula Margioula-Siarkou |
|
|
Oncological council: Alexios Papanikolaou, Konstantinos Dinas, Frederic Guyon, Angelos Sioutas, Stamatios Petousis, Anastasios Liberis, Pavlos Papakotoulas, Konstantina Mponiou, Stamatia Angelidou |
|
|
|
15:00-15:30 |
CLOSING REMARKS |
|
|
Konstantinos Dinas, Alexios Papanikolaou, Stamatios Petousis, Frederic Guyon |
|
|
